logo

Biological E’s Pneubevax 14 vaccine receives WHO’s pre-qualification

Biological E’s Pneubevax 14 vaccine achieves WHO pre-qualification, enhancing global access to vital pneumococcal disease protection for infants.

Read Full

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *